Medivizor - Health information, personalized.
Navigation Menu

COVID-19 Update: Why the New Booster is Important

COVID-19 Update: Why the New Booster is Important

Posted by on Oct 17, 2022 in Blog, Coronavirus / COVID-19 |

Are you up-to-date on what the latest advice is on getting a COVID-19 vaccine or booster?  If you’re not, you are not alone.   Public awareness of a new booster is “modest,” according to the results of a non-profit organization’s survey called the KFF COVID-19 Vaccine Monitor, published September 30th. Their survey found that fully half of...

Read More

Predicting the Risk of Getting Type 2 Diabetes: How do they know?

Predicting the Risk of Getting Type 2 Diabetes: How do they know?

Posted by on Sep 30, 2022 in Blog, Diabetes mellitus |

Are you ever skeptical when you see drug claims? One of my first questions when I read about a new drug or a statistic of some kind is: How do they know that? When I read about two new weight loss drugs presented at the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden (19-23 Sept), my antennae went up. Here’s the story. Drug...

Read More

Air Pollution Links to Lung Cancer

Air Pollution Links to Lung Cancer

Posted by on Sep 15, 2022 in Blog, Lung cancer |

While smoking remains the primary cause of lung cancer, 10 – 20% of people who develop non-small cell lung cancer (NSCLC) never smoked. NSCLC in non-smokers happens more often to women, and at an earlier age, than it does in smokers.  What would cause cancer to develop without smoking? [1] One theory is that environmental factors,...

Read More

Biomarkers, Combination Therapy, and Lung Cancer

Biomarkers, Combination Therapy, and Lung Cancer

Posted by on Aug 31, 2022 in Blog, Lung cancer |

KRAS, one gene present in some cancers, was considered “undruggable” for years.[1] Mutated KRAS is an important target for patients with non-small cell lung cancer (NSCLC) because it’s present in 20-25% of cases.[2]  Finally, one drug, sotorasib (Lumakras), is approved to treat one mutant form of KRAS gene, KRAS G12C.[3] This mutation appears in...

Read More

Coffee: The upside and the precautions

Coffee: The upside and the precautions

Posted by on Aug 18, 2022 in Blog |

Recent studies contribute to the evidence that there are benefits to drinking coffee.  Here’s the current scientific thinking on the subject. Recently published research: One study, published in 2022, examines data from a 16,000 person study called Atherosclerosis Risk in Communities (ARIC). ARIC’s study goal is to see if there’s any...

Read More

MMRD Rectal Cancers Disappear in Clinical Trial

MMRD Rectal Cancers Disappear in Clinical Trial

Posted by on Jul 31, 2022 in Blog, Colorectal cancer |

Fourteen people no longer have stage 2 or 3 rectal cancer because of an experimental use of immunotherapy.  Enrolling in a clinical trial has, for the past 25 months and counting, spared them from surgery, chemotherapy, and radiation, which are the standard treatments for colorectal cancer.  [1] Fourteen people may not sound like many, but it...

Read More

New standard of treatment for metastatic breast cancer

New standard of treatment for metastatic breast cancer

Posted by on Jul 17, 2022 in Blog, Breast cancer |

Each year in the United States, approximately 264,000 women and 2,400 men are diagnosed with breast cancer. Of those people, about  30% will go on to develop metastatic breast cancer (cancer that has spread beyond the breast, often to the brain, lungs, bones, or liver). Biopsies of breast cancer tissue determine if the surface of the cancer cells...

Read More

Re-engineering Venom into Medicine

Re-engineering Venom into Medicine

Posted by on Jun 28, 2022 in Blog |

Looking at other animals, reptiles, and insects with suspicion these days?  Despite the fact that the actual origins of the COVID-19 virus are still unknown, bats and the endangered pangolin were maligned as possible sources. We do know that the monkeypox virus originated in laboratory monkeys in 1958. To balance the bad publicity, there is also good...

Read More

Should CAR-T be used earlier for NHL patients?

Should CAR-T be used earlier for NHL patients?

Posted by on Jun 9, 2022 in Non-Hodgkin lymphoma |

CAR-T therapy is a relatively new immunotherapy treatment for advanced B-cell lymphomas, including non-Hodgkin’s lymphoma (NHL).  It is usually reserved for patients who have had more than one previous line of treatment but relapsed anyway. The standard course of treatment for non-Hodgkin’s lymphoma is chemotherapy, which cures about 70% of...

Read More